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RESEARCH ARTICLE
Reverse genetic screen reveals that Il34 facilitates yolk sac
macrophage distribution and seeding of the brain
Laura E. Kuil1,*, Nynke Oosterhof1,2,*, Samuël N. Geurts3,4, Herma C. van der Linde1, Erik Meijering3 and
Tjakko J. van Ham1,‡
ABSTRACT
Microglia are brain-resident macrophages, which have specialized
functions important in brain development and in disease. They
colonize the brain in early embryonic stages, but few factors that drive
the migration of yolk sac macrophages (YSMs) into the embryonic
brain, or regulate their acquisition of specialized properties, are
currently known. Here, we present a CRISPR/Cas9-based in vivo
reverse genetic screening pipeline to identify newmicroglia regulators
using zebrafish. Zebrafish larvae are particularly suitable due to their
external development, transparency and conserved microglia
features. We targeted putative microglia regulators, by Cas9/gRNA
complex injections, followed by Neutral-Red-based visualization of
microglia. Microglia were quantified automatically in 3-day-old larvae
using a software tool we called SpotNGlia. We identified that loss of
zebrafish colony-stimulating factor 1 receptor (Csf1r) ligand, Il34,
caused reduced microglia numbers. Previous studies on the role of
IL34 in microglia development in vivowere ambiguous. Our data, and
a concurrent paper, show that, in zebrafish, il34 is required during the
earliest seeding of the brain by microglia. Our data also indicate
that Il34 is required for YSM distribution to other organs. Disruption of
the other Csf1r ligand, Csf1, did not reduce microglia numbers in
mutants, whereas overexpression increased the number of microglia.
This shows that Csf1 can influence microglia numbers, but might not
be essential for the early seeding of the brain. In all, we identified il34
as a modifier of microglia colonization, by affecting distribution of
YSMs to target organs, validating our reverse genetic screening
pipeline in zebrafish.
This article has an associated First Person interview with the joint first
authors of the paper.
KEY WORDS: Reverse genetic screen, Microglia, Brain
development, Macrophages, Hematopoiesis
INTRODUCTION
Tissue macrophages, in addition to their immunological roles,
modulate organogenesis and exhibit organ-specific regulatory
properties that are thought to affect virtually all organs in
vertebrates (Gordon and Martinez-Pomares, 2017; Pollard, 2009).
Microglia are the brain’s residentmacrophages, and have roles in brain
development and homeostasis. Described functions of microglia
include the removal of dead cells and debris, modulation of neuronal
connectivity by synaptic pruning and maintenance of myelin-
producing cells (Colonna and Butovsky, 2017; Hagemeyer et al.,
2017; Salter and Stevens, 2017; Thion and Garel, 2017). Defects in
microglia function have been implicated in neurodevelopmental
disorders such as autism spectrum disorder (Salter and Stevens,
2017). Pathogenic variants in genes thought to primarily affect
microglia cause rare white matter disorders, including Nasu-Hakola
disease and adult-onset leukoencephalopathy with axonal spheroids
(ALSP),whichmay be caused by loss ofmicroglia activity (Oosterhof
et al., 2018; Paloneva et al., 2002; Rademakers et al., 2011; Sundal
et al., 2012). In line with this, there is accumulating evidence that
replenishing brain myeloid cells by hematopoietic cell transplantation
has powerful therapeutic potential in leukodystrophy and metabolic
diseases affecting the brain, and better understanding the molecular
regulation of brain colonization by microglia could lead to ways to
facilitate this (Eichler et al., 2016; Stepien et al., 2017; van Rappard
et al., 2016). However, the exact genes and mechanisms underlying
the emergence of microglia in the brain and acquisition of their
functional properties are still poorly understood.
Microglia originate frommacrophage progenitors in the embryonic
yolk sac, known as yolk sac macrophages (YSMs), which colonize
the brain during early embryonic development (Ginhoux et al., 2010;
Herbomel et al., 2001). Once they arrive in the brain, they acquire a
highly ramifiedmorphology, proliferate extensively and form a brain-
wide network with non-overlapping territories (Svahn et al., 2013).
The transition from YSM to mature microglia or other tissue-resident
macrophages involves several differentiation stages characterized by
distinct transcriptional profiles (Mass et al., 2016; Matcovitch-Natan
et al., 2016). The progression through these transcriptional states is
synchronized with, and most likely driven by, the different stages of
brain development, asmicroglia gene expression is highly sensitive to
changes in the microenvironment and tissue macrophage identity is
mostly determined by the host environment (Gosselin et al., 2014;
Lavin et al., 2014; Matcovitch-Natan et al., 2016; Thion et al., 2017).
For the majority of the genes specifically expressed in microglia, the
function is still unknown, and as many of these genes are rapidly
downregulated when they are taken out of the brain, it is difficult to
study their functions in vitro (Beutner et al., 2013; Gosselin et al.,
2017). In mammals, microglia development is relatively inaccessible
to study, as YSMs emerge during development in utero. Despite
progress in identifying methods to recreate microglia-like cells in
vitro, improved understanding of their ontogeny is needed to guide inReceived 26 October 2018; Accepted 6 February 2019
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vitro efforts (Lee et al., 2018; Muffat et al., 2016). Therefore,
identification of the functions of genes affecting microglia
development could provide valuable insights into regulation of
microglia development and function in vivo.
Zebrafish embryos are relatively small and transparent, relatively
easy to manipulate genetically and develop ex utero, which makes
them highly suitable for in vivo genetic studies (Oosterhof et al.,
2015). We recently showed that microglia gene expression is well
conserved between zebrafish and mammals and that, as shown in
mice, loss of the two zebrafish homologs of the colony-stimulating
factor 1 receptor (Csf1ra and Csf1rb) leads to absence of microglia
(Dai et al., 2002; Erblich et al., 2011; Oosterhof et al., 2017, 2018).
Phenotype-driven, forward genetic screens in zebrafish have
identified several microglia mutants with a defect in microglia
development or function. Processes affected in these mutants
include hematopoiesis, regulation of inflammation, phosphate
transport and lysosomal regulation, which implies that these
various processes are all critical for microglia development and
function (Demy et al., 2017; Meireles et al., 2014; Rossi et al.,
2015b; Shen et al., 2016; Shiau et al., 2013). However, such forward
genetic screens are laborious and relatively low throughput. A
candidate-driven reverse genetic screening approach could lead to
the identification of additional genes important for microglia. The
CRISPR/Cas9-system can be used to create insertions or deletions
(indels) in target genes via the repair of Cas9-induced double-strand
breaks by error-prone non-homologous end joining (NHEJ) (Cong
et al., 2013). Injection of gene-specific guide RNAs (gRNAs) and
Cas9 mRNA can lead to gene disruption sufficiently effective to
allow small-scale reverse genetic screening; for example, to identify
new genes involved in electrical synapse formation (Shah et al.,
2015). Alternatively, active Cas9-gRNA ribonucleoprotein
complexes (RNPs) injected into fertilized zebrafish oocytes can
more efficiently induce indels in target genes, and the resulting
genetic mosaic zebrafish can phenocopy existing loss-of-function
mutants (CRISPants) (Burger et al., 2016; Hwang et al., 2013).
Here, we present a scalable CRISPR/Cas9-based reverse genetic
screening pipeline in zebrafish to identify important genetic
microglia regulators using zebrafish. In zebrafish larvae, microglia
can be visualized by the vital dye Neutral Red (NR), which shows a
more pronounced staining in microglia over other macrophages and
has been used as an effective readout for microglia numbers in
forward genetic screens (Herbomel et al., 2001; Meireles et al., 2014;
Shen et al., 2016; Shiau et al., 2013). We developed an image
quantification tool, SpotNGlia, to automatically detect the brain
boundaries and count NR+ microglia. Of the 20 putative microglia
regulators we targeted by CRISPR/Cas9-mediated reverse genetics,
disruption of interleukin 34 (il34) showed the strongest reduction in
microglia numbers in developing zebrafish larvae. In mammals, IL34
is one of two ligands of the microglia regulator CSF1R. Further
analysis in stable il34 mutants revealed that il34 is mainly important
for the recruitment of microglia to the brain, and likely other tissue
resident macrophage populations, including Langerhans cells (LCs),
to their target organs. Thus, we here present a scalable reverse genetic
screening pipeline to identify additional new regulators important for
microglia development and function.
RESULTS
CRISPants phenocopy existing mutants with microglia
developmental defects
Loss of one of several key macrophage regulators, including Spi1
(encoding PU.1), Irf8 andCsf1r, and their zebrafish homologs spi1b
(Pu.1), csf1ra and csf1rb, and irf8, leads to defects in microglia
development (Erblich et al., 2011; Herbomel et al., 2001; Horiuchi
et al., 2012; Kierdorf et al., 2013; Rhodes et al., 2005; Shiau et al.,
2015; Su et al., 2007). To investigate whether Cas9-gRNA RNPs
targeting these regulators can be used to induce mutant microglia
phenotypes directly, we injected zebrafish oocytes with RNPs
targeting either csf1ra or spi1b. To assess whether CRISPR/Cas9-
based targeting of those genes affects microglia development, we
determined microglia numbers by NR staining at 3 days post-
fertilization (dpf ). At this time point, microglia have just colonized
the optic tectum, are highly phagocytic and have low proliferative
activity, which makes it an ideal time point to identify genes
required for the earliest steps of microglia development (Herbomel
et al., 2001; Xu et al., 2016). We quantified NR+ microglia in csf1ra
CRISPants, in controls and in csf1ra loss-of-function mutants found
in an N-ethyl-N-nitrosourea (ENU) mutagenic screen (hereafter
called csf1ra−/−) (Parichy et al., 2000). Similar to csf1ra−/−
mutants, csf1ra CRISPants showed an 80% reduction in the
number of NR+ microglia compared with controls, suggesting highly
effective targeting in F0 injected embryos (Fig. 1A). To assess the
targeting efficiency of the csf1ra gene, we performed Sanger
sequencing of the targeted locus of a small pool of csf1ra
CRISPants, and calculated the spectrum and frequency of indels in
the csf1ra gene using ‘tracking indels by decomposition’ (TIDE)
software (Brinkman et al., 2014). The mutagenic efficiency was
>90%, showing efficient mutagenesis (Fig. 1B). Similarly, spi1b
CRISPants showed a strong reduction in the number of microglia and
65-95% mutagenic efficiency (Fig. 1C,D). This shows that CRISPR/
Cas9-based mutagenesis can be used to reproduce mutant microglia
phenotypes in Cas9-gRNA-RNP-injected zebrafish larvae.
SpotNGlia semi-automatically counts microglia numbers
Manual quantification of NR+ microglia, across z-stack images, is
time consuming and can be subjective. To standardize and speed up
quantification, we developed a software tool, SpotNGlia, that
automatically counts NR+ microglia in the optic tectum, where most
microglia are located at 3 dpf. The SpotNGlia tool aligns stacked
images of stained zebrafish larvae taken at different axial positions
and blends the images into a single 2D image in which all NR+ cells
are in focus (Fig. 2A). Next, the images are segmented by using
polar transformation and dynamic programming to identify the
edges of the optic tectum. Finally, NR+ cells are detected and
counted by a spot detection technique based on multi-scale wavelet
products (Olivo-Marin, 2002). To test the SpotNGlia software tool,
we created and manually annotated a dataset with representative
z-stack images of 50 NR-stained zebrafish larvae. To assess the
accuracy of brain segmentation, Jaccard and Dice indices were
determined, revealing indices of 0.86 (Jaccard) and 0.93 (Dice)
(Fig. 2B,C). To assess the accuracy of microglia detection, we
determined the precision, recall and F1 scores of the computed
annotation, resulting in average scores of 0.85, 0.91 and 0.87,
respectively (Fig. 2B-D). These results indicate that SpotNGlia is
able to automatically identify the boundaries of the midbrain region,
and the microglia within that region, in the vast majority of cases. To
correct manually for those instances in which brain segmentation
and microglia detection were not completely accurate, as
determined by visual inspection, our tool offers the possibility of
post hoc correction. In our experiments, we have found that
SpotNGlia results in ∼80% reduction in the time it takes to quantify
NR+ microglia numbers. In all, this indicates that SpotNGlia is a
powerful tool for fast quantification of NR+ microglia numbers to
assist in identifying novel genes important for generation of
functional microglia.
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Reverse genetic screen reveals zebrafish Il34 as a regulator
of microglia development
To identify new microglia regulators using direct CRISPR/Cas9
targeting and microglia phenotyping by SpotNGlia, we targeted 20
candidate genes individually. These genes were selected based on
either our recently identified zebrafish microglia transcriptome (e.g.
slco2b1, hcst and mrc1b), microglia-expressed genes with a
connection to brain disease (e.g. usp18), or genes that can affect
microglia in a non-cell-autonomous manner (Csf1r-ligand-
encoding genes il34, csf1a and csf1b) (Fig. 3A; Fig. S1,
Table S1) (Oosterhof et al., 2017). Next, gRNAs were designed to
effectively target these genes in one of their first exons. Cas9-gRNA
RNPs targeting candidate genes were injected in fertilized oocytes,
after which they were NR stained at 3 dpf, phenotyped and
genotyped by Sanger sequencing, followed by indel decomposition
using TIDE (Table S1) (Brinkman et al., 2014). We did not observe
obvious signs of developmental delay, morphological abnormalities
or increased mortality upon Cas9-gRNA RNP injections, indicating
that the observed microglia phenotypes were not due to Cas9-gRNA
toxicity. The gRNAs for six of the targeted genes caused a
significant reduction in the number of NR+ microglia (Fig. 3A). The
largest decrease in NR+ microglia numbers was observed in
embryos in which the zebrafish homolog of IL34 was targeted
(Fig. 3A,B) (Wang et al., 2013).
To validate our approach and confirm that this microglia
phenotype is caused by loss of il34 function, we generated a
Fig. 1. csf1r CRISPants phenocopy existing csf1r
microglia mutants. (A) Neutral Red (NR+) images and
quantification of wild-type (WT), csf1ra−/− and csf1ra
CRISPant zebrafish larvae at 3 dpf. (B) Indel spectrum of a
pool of csf1raCRISPants calculated by TIDE. (C) NR images
and quantification of WT and spi1b CRISPant zebrafish
larvae at 3 dpf. (D) Indel spectrum of a representative
individual spi1b CRISPant calculated by TIDE. The R2 value
represents reliability of the indel spectrum. ***P<0.001. One-
way ANOVA and Student’s t-test. Each dot represents one
larva. Error bars represent s.d.
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premature stop codon in exon 5 of the il34 gene (Fig. 2C). NR
labeling of homozygous il34 mutants at 3 dpf revealed a ∼60%
reduction in NR+ microglia compared with wild-type siblings,
suggesting that this is a loss-of-function allele (Fig. 3D).
Similarly, live imaging of GFP+ microglia, driven by the mpeg1
(also known as mpeg1.1) promoter, in the optic tecti of il34
mutants showed lowered microglia numbers compared with
controls (Fig. 3E). In mice, Il34 knockout led to slightly
different outcomes, causing, in one study, lowered microglia
numbers in early postnatal development that remained low into
adulthood and, in another study, only reduced adult microglia
numbers (Greter et al., 2012; Wang et al., 2012). Therefore, the
precise role of IL34 in early microglia development remains
ambiguous. In addition, the precise role of IL34 in adult
microglia has not been described yet (Greter et al., 2012; Wang
et al., 2012). Our results are consistent with an evolutionarily
conserved role for Il34 in early microglia development (Wang
et al., 2012). This is further supported by a concurrent study
in which, using another premature stop mutation in il34,
the authors showed a similar reduction in microglia numbers
at the same developmental stage (Wu et al., 2018). Interestingly,
the receptor for Il34, Csf1r, has two other ligands in zebrafish:
Csf1a and Csf1b. To determine whether the other Csf1r ligands
also affect early microglia development, we generated stable
frameshift mutants for csf1a and csf1b (Fig. S3). However,
individual csf1a and csf1b mutants did not show reduced
microglia numbers (Fig. S2A,B) (Wu et al., 2018). Surprisingly,
larvae containing mutations in both zebrafish csf1 homologs,
csf1a and csf1b (csf1a−/−b−/−), also showed no reduction in
microglia numbers (Fig. S2C). As the mutants presented with
the absence of yellow pigment cells, known as xanthophores, a
phenotype also observed in csf1ra−/− mutants, this suggests that
the csf1a−/−b−/− fish are loss-of-function mutants (Parichy et al.,
2000; Parichy and Turner, 2003; Patterson et al., 2014; Patterson
and Parichy, 2013). Many in vitro studies have shown that CSF1
can induce proliferation of myeloid cells (Stanley and Chitu,
2014; Tushinski and Stanley, 1985). Consistently, we found that
overexpression of Csf1a [Tg(hsp70l:csf1a-IRES-nlsCFP)
(Patterson and Parichy, 2013)] caused an increase in microglia
numbers quantified (Fig. S2D). These data suggest that
Fig. 2. SpotNGlia semi-automatically counts microglia numbers. (A) Examples of z-stack images of NR-stained larvae and a schematic representation
of the SpotNGlia analysis pipeline. (B) SpotNGlia output of test dataset with both manual (blue) and automated (red) brain segmentation and NR+ microglia
annotation. (C) Box plots showing Jaccard and Dice indices for accuracy of brain segmentation and F1, precision and recall scores for the accuracy of NR+
microglia annotation. This is a Tukey boxplot: it uses the median and interquartile range (IQR) for the box. The whiskers extend to the most extreme data within
1.5×IQR. Data outside 1.5×IQR are considered outliers. (D) Correlation between manually and automated microglia quantification after manual correction for
segmented brain area. Error bars represent s.d.
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Fig. 3. See next page for legend.
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increased Csf1a is capable of influencing microglia numbers,
but Csf1 is not essential for early microglia development. In all,
the loss of Il34, but not Csf1, causes a reduction in microglia
numbers in 3 dpf zebrafish.
Il34 facilitates the distribution of macrophages, without
affecting their proliferation
In mice, tissue-resident macrophages of the skin, known as LCs, are
highly dependent on IL34/CSF1R signaling for their maintenance
and self-renewal (Greter et al., 2012; Wang et al., 2012, 2016).
We therefore hypothesized that Il34 in zebrafish might regulate the
proliferative expansion of microglia, similar to LCs in mice, leading
to the lower microglia numbers we observed. Microglia numbers
increase sharply after 3 dpf and, to determine whether microglia
numbers remained lower over time, we quantified NR+ microglia
also at 5 dpf (Fig. 4A). Surprisingly, compared with 3 dpf,
microglia numbers in il34−/− mutants were closer to those of
controls at 5 dpf (∼30% reduction at 5 dpf versus ∼60% reduction
at 3 dpf ). To determine whether the increase in numbers was due to
the continuation of seeding the brain or proliferative expansion,
we performed 5-ethynyl-2’-deoxyuridine (EdU) pulse labeling
between 3 dpf and 4 dpf. EdU/L-plastin double labeling showed
reduced microglia and reduced Edu+ microglia, but the fraction of
EdU+ microglia did not differ between il34 mutants and controls
(Fig. 4B; Fig. S4A). Thus, loss of il34 does not change the
proliferative fraction of microglia; therefore, the decreased
microglia numbers are unlikely explained by a defect in
proliferation. Since the decrease in microglia numbers in il34
mutants compared with controls was largest at 3 dpf, Il34 likely
affects YSMs, including microglia progenitors, preceding brain
colonization. Indeed, Wu and colleagues show that Il34 deficiency
causes impaired colonization by failing to attract YSMs to enter the
brain in a Csf1ra-dependent mechanism (Wu et al., 2018). We used
live imaging to visualize mpeg1-GFP+ YSMs, which are the
progenitors of microglia but also of many other macrophages at this
stage. At 2 dpf, YSM numbers and morphology were not different
between il34 mutants and controls (Fig. 4C). Thus, reduced
microglia numbers are likely not attributed to reduced YSM
numbers. Therefore, impaired migration of il34-deficient YSMs
towards the brain could explain the lower microglia numbers.
Imaging in the rostral/head region at 2 dpf showed an >80%
decrease in the number of macrophages/microglia, suggesting that
il34 is indeed involved in the recruitment of YSMs to the brain
(Fig. 4D). To determinewhether this effect is exclusive to microglia,
we determined the fraction of total macrophages that was found in
the head or in the trunk region at 3 dpf. This showed again an ∼80%
reduced infiltration of microglia in the brain in il34 mutants
compared with controls. Colonization of the trunk was also
decreased in il34 mutants compared with controls, but to a lesser
extent (∼ 25% reduction) (Fig. 4E,F; Movie 1). This was confirmed
by time-lapse imaging of il34 mutants and controls, which showed
largely reduced colonization of all embryonic regions (Movie 1). In
addition, we observed frequent proliferative events between 2 and 3
dpf, both in control but also in il34 mutant larvae, and therefore
proliferation of il34−/− YSMs caused an increase in the number
of YSMs that had infiltrated the tissue (Movie 1). Analysis of entire
larvae at 8 dpf revealed that total macrophage numbers were
not reduced in il34 mutants, suggesting normal macrophage
development and expansion. However, whereas in control fish
almost 60% of the total macrophages were found to have migrated
away from the hematopoietic sites into the embryonic tissues, in il34
mutant fish only 40% of the macrophages colonized the embryo.
Therefore, loss of Il34 affects the distribution of macrophages into
various embryonic tissues including the brain, analogous to the
effect of IL34 on the maintenance and development of LCs, as
described in mice (Greter et al., 2012; Wang et al., 2012, 2016)
(Fig. 5).
DISCUSSION
In this study, we developed a scalable CRISPR/Cas9-based
reverse genetic screening pipeline using semi-automated image
quantification to identify new regulators of microglia biology using
zebrafish embryos. We showed that direct genetic targeting of
known microglia regulators, including csf1ra and spi1b, by Cas9/
gRNA injections in zebrafish embryos phenocopies previously
identified microglia mutants. We next developed a software tool
(SpotNGlia) that allows for automated phenotyping by
quantification of NR+ microglia. As zebrafish are well suited for
in vivo drug discovery, our strategy could potentially also be used to
identify small molecules affecting microglia development (Zon and
Peterson, 2010). Using this pipeline, we here tested 20 candidate
genes for a role in microglia development and found six genes
significantly affecting microglia numbers when mutated. Loss of
il34 function caused the largest decrease in microglia numbers,
which we confirmed by analysis of stable il34 mutants.
Furthermore, we uncovered Il34 as a regulator of distribution of
tissue macrophages, needed to recruit YSMs to the brain and other
embryonic tissues.
Even though we here examined 20 genes, there are several ways to
increase the throughput of our screening strategy. First, mounting of
the injected zebrafish larvae and subsequent image acquisition are
the most time-consuming parts of our pipeline. NR-stained larvae
were manually embedded in low-melting-point agarose before
imaging, which restricts the number of animals that can be screened
per day. Automated imaging systems that can load zebrafish larvae
from liquid medium in multi-well plates and image them in the
orientation of interest in glass capillaries could overcome this hurdle
(Pardo-Martin et al., 2010). Together with the SpotNGlia tool, this
would permit a significantly increased screening throughput and
efficiency. Additionally, we aimed to achieve maximal CRISPR/
Cas9 mutagenic efficiency for individual genes of interest, and
therefore targeted individual genes. Shah et al. previously reported
a strategy by which pools of up to eight gRNAs are injected
simultaneously to target multiple genes at once (Shah et al., 2016),
which could lead to reduced targeting efficiency of the individual
gRNAs. Although a pooling strategy could significantly increase
the number of genes that can be screened, we observed that,
especially for genes with a relatively subtle microglia phenotype, a
high mutagenic efficiency increases the chance of detecting the
Fig. 3. Reverse genetic screen reveals zebrafish il34 as a regulator of
microglia development. (A) Accumulated data from all gRNA injections
showing the number of NR+ microglia as quantified with SpotNGlia. Magenta
bars represent genes showing a significant reduction in microglia numbers
upon CRISPR/Cas9-based targeting (black bar, control; green bars, genes
with non-significant reduction in microglia numbers). (B) NR+ microglia
numbers in 3 dpf zebrafish larvae injected with gRNA-Cas9 RNPs targeting
il34. Controls in A and B are non-injected WT larvae. (C) A −5 bp deletion in
exon 1 of il34 directly introduces a stop codon. (D) NR+ microglia numbers in
il34mutants with a premature stop codon in exon 5 and their heterozygous and
WT siblings at 3 dpf. (E) GFP+microglia in the optic tecti (dashed lines) of 3 dpf
il34 mutants and controls, and quantification of their numbers and the fraction
of microglia containing more than one protrusion (ramified microglia). Controls
in D and E are WT (il34+/+) larvae. *P<0.05, **P<0.01, ***P<0.001. One-way
ANOVA and Student’s t-test. Bonferroni correction for multiple testing. Scale
bars: 100 µm. Each dot represents one larva. Error bars represent s.d.
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Fig. 4. See next page for legend.
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phenotype. Additionally, due to the clonal nature of hematopoietic
progenitors, including yolk sac macrophages, a high targeting
efficiency is likely required, because non-targeted cells could
expand and compensate for mutated cells.
IL34 is one of two ligands of CSF1R, a main regulator of
development of the macrophage lineage (Stanley and Chitu, 2014).
Even though adult Il34-deficient mice have fewer microglia, and no
LCs, the precise role of IL34 in microglia development is unclear.
Wang and colleagues showed that neonatal Il34−/−mice have lower
microglia numbers, whereas Greter et al. showed normal microglia
numbers in Il34−/− mice throughout embryonic development
(Greter et al., 2012; Wang et al., 2012). The exact function of
IL34 in microglia development in vivo, and how this may differ
from that of CSF1, therefore, remains ambiguous. These
discrepancies could be attributed to factors such as genetic
background, or slightly different methods leading to different
interpretations regarding the role of IL34 in embryonic and early
postnatal microglia numbers (Greter et al., 2012; Wang et al., 2012).
Our data revealed a ∼60% reduction in microglia numbers in il34
mutant larvae at 3 dpf, indicating that il34 is required for early
microglia development in zebrafish. We show that, upon arrival in
the brain, between 3 dpf and 5 dpf, microglia numbers increase by
proliferation in both controls and il34 mutants, suggesting that the
proliferative capacity of microglia is not affected by the loss of il34
(Fig. 5). In addition, YSM numbers were not affected by il34
deficiency, indicating that there is a defect in the colonization of the
embryonic brain, likely due to a failure to attract YSMs expressing
Csf1ra and/or Csf1rb. Consistent with this, analysis of migration
towards the brain at both 2 dpf and 3 dpf showed that much fewer
microglia colonized the brains of il34-deficient larvae. Our findings
are consistent with a concurrent paper, in which the authors show
that nervous system expression of Il34 can attract YSMs to migrate
into the brain by the Il34/Csf1 receptor Csf1ra (Wu et al., 2018).
However,we additionally found that distributionof il34mutantYSMs
into trunk regions was reduced, indicating that the effect of Il34 is not
limited to microglia, but also affects the migration and colonization of
other tissue-resident macrophages. Consistent with this idea, recent
single-cell RNA sequencing studies show widespread expression of
il34 mRNA in early embryonic zebrafish (Wagner et al., 2018). At
24 hours post-fertilization (hpf), il34 is already expressed in e.g. the
brain, but also in muscle, heart, pharyngeal arches, epidermis and
neural crest (Wagner et al., 2018). In mouse, IL34 is also expressed in
the brain during embryonic development (E11.5, and possibly earlier)
and, for example, in the epidermis (Greter et al., 2012; Wei et al.,
2010). This early expression in brain and other cells supports our
model that Il34 attracts YSMs towards the brain and into other parts of
the embryo, including the epidermis.
We previously showed that mutants for both receptors, Csf1ra
and Csf1rb, lack all microglia, in contrast to Csf1ra mutants, which
have fewer microglia only in early development. Therefore, the
expansion of microglia following colonization of the brain is likely
regulated by other, possibly compensatory or redundant, factors,
including through the CSF1 homologs Csf1a or Csf1b (Dai et al.,
2002; Oosterhof et al., 2018). Although we repeatedly identified a
decrease in microglia numbers in csf1a gRNA-injected zebrafish,
we did not identify a change in csf1a mutants, generated with the
same gRNA. Our data are consistent with an already-published
csf1a mutant line that also shows normal microglia numbers (Wu
et al., 2018). Even when we combined csf1a and csf1b frameshift
mutations, we did not find reduced microglia numbers. The
pigmentation phenotype observed in csf1a−/−b−/− larvae, and not
in the individual mutants, suggests that the mutations in csf1a and
csf1b are loss of function and possibly compensate for each other.
This suggests that genetic compensation, where alternative
pathways are upregulated upon mutation of exonic regions, does
not occur regarding the pigment phenotype (El-Brolosy et al., 2018;
Rossi et al., 2015a). It is likely that loss of all three ligands (Csf1a,
Csf1b and Il34) leads to a similar microglia phenotype, as observed
Fig. 4. Il34 does not affect proliferation but does affect the distribution of
YSMs to target organs. (A) NR+ microglia numbers in il34 mutants and their
heterozygous and WT siblings at 5 dpf. (B) EdU/L-plastin staining of microglia
in the optic tecti (dashed lines) of 4 dpf il34 mutants and WT controls, and
quantification of microglia numbers, EdU+ microglia numbers and the fraction
of EdU+ microglia among total numbers. (C) In vivo imaging of GFP+
macrophages located on the yolk sac (dashed lines) in il34 mutants and WT
controls, transgenic for mpeg1-GFP, and quantification at 48 hpf. YSMs with
more than one protrusion were counted as branched YSMs. (D) In vivo imaging
ofmpeg1-GFP+ macrophages located in the head region (dashed lines) in il34
mutants and WT controls, and quantification at 48 hpf. (E) In vivo imaging of
GFP+ macrophages located in the head region (dashed lines) in il34 mutants
andWT controls, and quantification at 3 dpf. a, outline of the head region. (F) In
vivo imaging ofmpeg1-GFP+ macrophages located in the tail (dashed lines) in
il34 mutants and WT controls, and quantification. b, outline of the embryonic
region/trunk region. Scale bars: 100 µm. *P<0.05, **P<0.01, ***P<0.001.
One-way ANOVA and Student’s t-test. Each dot represents one larva. Error
bars represent s.d.
Fig. 5. Schematic representation of the role of Il34 in distribution of YSMs
to target organs. (Upper panels) In control 2-day-old larvae, macrophages
from the yolk migrate into the embryonic tissue guided by Il34 (blue arrows).
In il34 mutants, yolk sac macrophages largely fail to migrate towards the
embryonic tissues, leading to reduced colonization of, in particular, the brain.
(Lower panels) Microglia are less abundant in 5-day-old larvae due to il34
deficiency, but continue to proliferate independently of Il34. Blue arrows
indicate the direction of macrophage migration into the embryo, induced by
Il34. Black arrows indicate cell division. Gray indicates the area of the brain.
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in csf1r knockouts. Our csf1 gRNA injections reduce microglia
numbers, and overexpression of csf1a increases microglia numbers.
Therefore, csf1 in zebrafish seems capable of influencing microglia
numbers. We cannot currently explain the discrepancy between
results obtained with gRNA injections and stable mutants, and it is
possible that genetic compensation for csf1, perhaps by other
ligands, could occur in csf1 mutants regarding microglia. This
stresses the importance of using multiple independent approaches to
detect false-positive, and also false-negative, results (El-Brolosy
et al., 2018; Kok et al., 2015; Rossi et al., 2015a).
Csf1 and Il34 were both found to be expressed in the adult mouse
brain, although in non-overlapping regions; however, during early
embryonic development, IL34 expression precedes CSF1
expression in mice (Nandi et al., 2012; Wang et al., 2012). This
corroborates our findings that Il34 acts as a beacon for YSMs to
migrate towards the brain, whereas loss of Csf1 appears not to
affect microglia numbers at this early developmental stage. In il34
mutants, YSMs that arrive in the brain at 3 dpf start to proliferate
and reach 70% of control levels at 5 dpf. Time-lapse imaging
showed frequent proliferative events in other tissues of il34
mutants as well. Thus, we find that, whereas Csf1 appears able to
influence microglia numbers, it seems not essential for early
embryonic microglia development. On the other hand, il34 is a
critical, non-cell-autonomous regulator of seeding of the brain and
other organs by YSMs, but does not appear to be required for their
proliferation.
In conclusion, we here present a scalable reverse genetic
screening method for the identification of novel regulators of
microglia development and function. Microglia are key players in
brain disease and there is strong evidence that microglia defects can
be a primary cause of brain disease (Oosterhof et al., 2018; Paloneva
et al., 2002; Rademakers et al., 2011; Sundal et al., 2012).
Replenishing microglia; for example, by hematopoietic stem cell
transplantation, can provide therapeutic benefit in human brain
diseases. Better understanding of microglia development, and
acquisition of their specific cell fate in vivo, could lead to improved
strategies to replace defective microglia. However, the mechanisms
and genes regulating microglia development and function are still
largely unknown. Therefore, better understanding of microglial
gene functions could be a valuable step in the elucidation of
mechanisms underlying microglial biology. As zebrafish larvae
have proven their suitability for drug discovery, SpotNGlia
automated analysis software in combination with automated
imaging systems could also be used to screen for compounds
affecting microglia (MacRae and Peterson, 2015). In all, we
identified il34 as a regulator of tissue-resident macrophage
distribution, primarily affecting macrophage colonization of the
zebrafish embryonic brain by affecting the recruitment of YSMs to
target organs including the brain. Our reverse genetic screening
pipeline can be used to address genetic regulation of microglia
development and function, and identify regulators essential to
generate functional microglia in vivo.
MATERIALS AND METHODS
Fish care
For all experiments, Tg(mpeg1:EGFP) fish expressing GFP under the
control of the mpeg1 promotor or Tg(Neuro-GAL4, UAS:nsfB-mCherry,
mpeg1:EGFP) with neuronal specific nitroreductase expression,
transgenic zebrafish lines were used (Ellett et al., 2011). Zebrafish
embryos were kept at 28°C on a 14 h/10 h light-dark cycle in HEPES-
buffered E3 medium. At 24 hpf, 0.003% 1-phenyl 2-thiourea (PTU)
was added to prevent pigmentation. For overexpression of Csf1a, we
used Tg(hsp70l:csf1a-IRES-nlsCFP)wp.r.t4 fish kindly provided by
David Parichy (University of Virginia, Charlottesville, VA, USA)
(Patterson and Parichy, 2013). Fish were heat shocked twice at 37°C for
1 h at 4 dpf. After heat-shock treatment, fish were selected on CFP
expression and divided into CFP– controls and CFP+ fish. In this paper,
we describe three new mutant fish lines: il34re03/re03 containing a 5 bp
deletion in exon 5 (Fig. 2C); csf1are05/re05 containing a 4 bp insertion in
exon 2; csf1bre06/re06 containing a 4 bp deletion in exon 2, and a version
in the csf1are05/re05 background containing a −3 bp deletion and +28
insertion, leading to a +25 bp insertion causing a frameshift in exon 2
(csf1bre07/re07) (Fig. S4).
Ethics statement
Animal experiments were approved by the Animal Experimentation
Committee at Erasmus University Medical Center, Rotterdam, The
Netherlands. Zebrafish embryos and larvae were anesthetized using
tricaine and euthanized by ice water.
sgRNA synthesis
To design single-guide RNAs (sgRNAs), the online program
CRISPRscan (www.crisprscan.org) was used (Moreno-Mateos et al.,
2015). The gRNAs were designed to target exons, except for exon 1, to be
as close as possible to the transcription start site and to have no predicted
off-target effects. The sgRNAs were generated from annealed primers,
one containing a minimal T7 RNA polymerase promoter, the target
sequence, and a tail-primer target sequence and a generic tail-end primer
(Vejnar et al., 2016). To generate primer dimers, the FastStart™ High
Fidelity PCR System from Sigma-Aldrich was used. A solution was
prepared, containing 1 mM forward sgRNA oligonucleotide, 1 mM
reverse oligonucleotide consisting of 20-nucleotide overlap with
sgRNA oligonucleotide and the Cas9-binding part, 0.8 mM dNTPS, 1×
FastStart Buffer and 6.25 U/µl FastStart Taq polymerase in 20 µl total
volume. Annealed DNA oligonucleotide dimers were generated by
denaturation at 95°C for 5 min followed by annealing by reducing the
temperature by 1°C per second over 20 s to 75°C and extension at 72°C
for 10 min. The gRNAs were synthetized from annealed DNA
oligonucleotides, containing a minimal T7 RNA polymerase promoter,
with the mMESSAGE mMACHINE™ T7 ULTRA Transcription Kit
(Invitrogen), according to the manufacturer’s instructions.
Cas9/gRNA complex injections into zebrafish larvae
The SP-Cas9 plasmid used for the production of Cas9 protein was Addgene
plasmid #62731, deposited by Niels Geijsen (D’Astolfo et al., 2015). Cas9
nuclease was synthetized as described (D’Astolfo et al., 2015). gRNA (600-
900 ng) was mixed with 4 ng Cas9 protein to form active gRNA-Cas9
RNPs. Next, 0.4 µl of 0.5% Phenol Red (Sigma-Aldrich) was added, and the
volume was adjusted with 300 mM KCl to a total volume of 6 µl.
Approximately 1 nl of the mix was injected into fertilized zebrafish oocytes.
For the creation of mutant lines, CRISPants were grown to adulthood and
outcrossed to the AB background, and Sanger sequencing was used to
identify mutations.
NR staining and imaging
To label microglia, 3 dpf or 5 dpf larvae were incubated in E3 medium
containing NR (Sigma-Aldrich) (2.5 µg/ml) for 2 h at 28°C, after
which they were rinsed with E3 medium containing 0.003% PTU.
Larvae were anesthetized with 0.016% MS-222 and embedded in
1.8% low-melting-point agarose in E3 medium with the dorsal side
facing upwards. Serial images (3-6) in the z-plane were acquired with
a Leica M165 FC microscope using the 12× dry objective and a Leica
DFC550 camera.
Larvae genotyping (Sanger sequencing)
Lysis
Zebrafish larvae were euthanized and placed in single tubes containing
100 µl lysis buffer (0.3% 1 M KCl, 1% 1 M Tris-HCl pH 9.0, 0.1% Triton,
0.15 mg/ml Proteinase K) per larva. The mix was incubated at 55°C for
10 min and 95°C for 10 min. The lysate was centrifuged for 5-10 min at
4000 rpm (1500 g), and 1 µl was used for PCR.
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Sanger sequencing to determine CRISPR/Cas9 targeting efficiency
For Sanger sequencing, 500 bp long PCR products were obtained.
For the sequencing reaction, a BigDye® Terminator v3.1 Cycle
Sequencing Kit from Applied Biosystems was used. The product
was placed on Sephadex® columns (Sigma-Aldrich) and centrifuged at
910 rcf (910 g) for 5 min. The ABI 3130 genetic analyzer from Applied
Biosystems was used for Sanger sequencing. To assess the indel
spectrum and frequencies at the target locus, we used the program
TIDE developed by the Netherlands Cancer Institute (NKI) (Brinkman
et al., 2014).
SpotNGlia
The SpotNGlia software tool was developed in MATLAB (MathWorks,
Natick, MA, USA). Its full source code and a technical description of how to
use the tool is available from GitHub (https://github.com/samuelgeurts/
SpotNGlia). The software is released under the GNU General Public
License. A brief description of the three main steps (pre-processing, brain
segmentation and microglia detection) performed by the software is given
below.
Pre-processing
Images acquired from NR-labeled larvae (n=50) were used to optimize the
algorithm. For each larva, 3-6 images were taken at different depths of focus.
Color channels were realigned by finding the translation that maximizes the
correlation coefficient (Evangelidis and Psarakis, 2008). To remove the
background, the triangle thresholding method was used (Zack et al., 1977).
Next, we generated an all-in-focus image with extended depth of field
(Forster et al., 2004).
Brain segmentation
The orientation of the fish was determined by maximizing the correlation
coefficient between the image and a mirrored version of itself, yielding the
larva’s rotation angle. The translation parameters were found by directly
correlating the image to a template image, which was established by
averaging multiple aligned fish. Because of its near-circular shape, the optic
tectumwas segmented by performing a polar transformation, after which the
edges of the optic tectum were found by using Dijkstra’s algorithm
(Dijkstra, 1959; Zinser and Komitowski, 1983). The brain edge becomes an
approximately straight line in polar coordinates if it is transformed with
respect to the center of the optic tectum, which we obtained from the
template image. To make it applicable for the shortest path algorithm, the
image was correlated with a small image, similar to the average appearance
of the brain edge in the polar image. Also, a priori information of the
training set was used to exclude locations in which the brain edge cannot be.
After Dijkstra’s algorithm was applied, the found path was transformed
back, resulting in the brain edge coordinates.
Microglia detection
To identify NR+ microglia, a multi-scale wavelets product was computed
on the green channel of the image, which contains the highest contrast for
the NR signal (Olivo-Marin, 2002). Multiple smoothed images from a
single fish image were produced with increasing spatial scale. Subtracting
adjacent smoothed images resulted in sub-band images containing
different scales of detail present in the image. Sub-band images in the
range of the microglia spot size were combined by pixel-wise
multiplication to obtain an image with only high values at the location
of the spots, i.e. the multi-scale wavelet product. A threshold on the multi-
product image was applied to obtain a binary image to determine the
spots. The identified spots were discriminated further on typical color and
size obtained from the training set, resulting in accurate quantification of
microglia numbers. All NR quantifications were performed using
SpotNGlia, except for the 5 dpf larvae in Fig. 4A and Fig. S2D.
Immunofluorescence staining
Immunohistochemistry was performed as described (van Ham et al., 2012,
2014). Briefly, larvae were fixed in 4% paraformaldehyde (PFA) at 4°C
overnight. Subsequently, they were dehydrated in 100% MeOH, stored at
−20°C for at least 12 h and rehydrated in PBS. Then, they were incubated in
blocking buffer [10% goat serum, 1% Triton X-100 (Tx100), 1% bovine
serum albumin (BSA), 0.1% Tween-20 in PBS] for 3 h at 4°C, before
incubation in primary antibody buffer at 4°C overnight. Larvae were washed
in 10% goat serum, 1% Tx100 in PBS and PBS containing 1% Tx100 for a
few hours, followed by incubation in secondary antibody buffer at 4°C
overnight. Primary antibody buffer contained 1% goat serum, 0.8% Tx100,
1% BSA and 0.1% Tween-20 in PBS. Secondary antibody buffer contained
0.8% goat serum, 1% BSA and PBS containing Hoechst. Primary antibody
against L-plastin (1:500) was a gift from Yi Feng (University of Edinburgh,
Edinburgh, UK). Secondary antibody was DyLight Alexa Fluor 488 (1:250).
EdU pulse-chase protocol
Larvae of 3 dpf were placed in a 12-well plate in HEPES-buffered (pH 7.3)
E3 medium containing 0.003% PTU and 0.5 mM EdU for 24 h. Next, larvae
were fixed in 4% PFA at 4°C overnight, dehydrated in 100% MeOH and
stored at −20°C for at least 12 h. They were then rehydrated in PBS in series
and incubated in proteinase K (10 µg/ml in PBS) for 1 h at room temperature,
followed by 15 min post-fixation in 4% PFA. Larvae were incubated in 1%
dimethyl sulfoxide in PBS containing 0.4% Triton X-100 for 20 min. Then,
50 µl Click-iT™ (Invitrogen) reaction cocktail was added for 3 h at room
temperature, protected from light. Samples were subjected to immunolabeling
using L-plastin antibody (see ‘Immunofluorescence staining’ section).
Confocal imaging
Intravital imaging was largely performed as previously described (van Ham
et al., 2014). Briefly, zebrafish larvae were mounted as described for NR
staining. The imaging dish containing the embedded larva was filled with
HEPES-buffered E3 medium containing 0.016%MS-222. Confocal imaging
was performed using a Leica SP5 intravital imaging setup with a 20×/1.0 NA
water-dipping lens. Imaging of GFP and L-plastin labeled with Alexa Fluor
488 was performed using the 488 nm laser; imaging of EdU labeled with
Alexa Fluor 647 was performed using the 633 nm laser. Analysis of imaging
data was performed using ImageJ (Fiji) and LAS AF software (Leica). The
sequence in which larvae were imaged (live imaging) was randomized to
avoid any adverse effects due to the anesthetics or to mounting.
Statistical analysis
For image processing and quantitative analysis, SpotNGlia, ImageJ and
Prism (GraphPad) were used. Statistical significance was calculated using
one-way ANOVAwith Bonferroni correction or Student’s t-tests. Error bars
represent s.d. and P<0.05 was considered significant. Fish showing signs of
developmental delay, improper staining or incorrect mounting and/or
annotation by SpotNGlia were excluded.
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